Abstract: Disclosed is a computer-implemented method for recommending booths-to-visit to a user, comprising the following steps: accessing a user record, wherein the user record includes data indicative of booths which a user corresponding to the user record has visited in an exhibition; determining similarity level between records in a history database and the user record, the records in the history database including data indicative of the booths visited by previous visitors in the exhibition; selecting several of the records according to the determined similarity level; determining the booths in the all of the selected records not yet visited by the user; adding the determined booths to a candidate list; and presenting at least one of the booths in the candidate list to the user.

Abstract: Disclosed is a computer-implemented method for recommending booths-to-visit to a user, comprising the following steps: accessing a user record, wherein the user record includes data indicative of booths which a user corresponding to the user record has visited in an exhibition; determining similarity level between records in a history database and the user record, the records in the history database including data indicative of the booths visited by previous visitors in the exhibition; selecting several of the records according to the determined similarity level; identifying shared ones of the selected records; determining the booths in the shared ones of the selected records not yet visited by the user; adding the determined booths to a candidate list; and presenting at least one of the booths in the candidate list to the user.

Abstract: Disclosed is a computer-implemented method for recommending booths-to-visit to a user, comprising the following steps: accessing a user record, wherein the user record includes data indicative of booths which a user corresponding to the user record has visited in an exhibition; determining similarity level between records in a history database and the user record, the records in the history database including data indicative of the booths visited by previous visitors in the exhibition; selecting one of the records according to the determined similarity level; determining the booths in the selected record not yet visited by the user; obtaining the user's current location in the exhibition; determining a target booth, from the booths not yet visited by the user, by referring to the current location and a map database; and sending to the user a message indicative of the target booth.

Abstract: A pharmaceutical preparation containing polymeric compounds as shown in the specification. This preparation can be used to improve liver function and treat liver disease, and promoting liver tissue regeneration.

Abstract: A method for recovering metal from electronic waste contacting electronic waste with a recovery solution to dissolve metals from the electronic waste into the recovery solution, wherein the recovery solution comprises nitric acid and ferric nitrate; and raising the pH of the recovery solution to precipitate at least some of said metals therefrom.

Abstract: A hollow fiber for adsorption or filtration. The hollow fiber contains a tubular matrix having a first end and a second end, and a winding channel formed through the tubular matrix and extending between the first end and the second end. The tubular matrix is porous and has a surface-area-to-volume ratio of 10 to 20000 m2/m3, a thickness of 0.05 to 9.95 mm, an outside diameter of 0.1 to 10 mm, and a length 10 to 90% that of the winding channel. Also disclosed is a method of preparing this hollow fiber.

Abstract: A pharmaceutical composition prepared from a Boehmeria species. This composition can be used to improve liver function and treat liver disease, and promoting liver tissue regeneration.

Abstract: A process for the in-situ formation of a lubricating phase comprising sulphur and tin in a friction material, wherein reaction of a sulphur source with a tin source in said friction material results in the formation of said lubricating phase, and wherein said reaction is initiated or effected by heat resulting, in use, from the generation of friction, wherein said sulphur source is selected from one or both of sulphur and/or a metal sulphide selected from one or more of iron, copper, zinc, titanium and bismuth, and wherein said tin source is selected from one or more of tin, a tin-containing compound and/or a tin-containing alloy.

Abstract: Provided herein is a method for detection of migratory and invasive cancer cells based on a number of marker nucleic acids differentially expressed in migratory/invasive cancer cells relative to nonmigratory/noninvasive cancer cells. Also disclosed are antisense oligonucleotides of the marker nucleic acids and uses thereof for suppressing cancer cell migration and invasion.

Abstract: The present invention provides a method for detecting liver fibrotic injury, including fibrosis and/or cirrhosis, by assaying biological samples for differential expression of at least one gene encoding a protein chosen from SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof, wherein differential expression of at least one gene suggests the presence of liver fibrosis or cirrhosis. The invention also provides a kit containing nucleic acid probes or antibodies for detecting liver fibrosis and/or cirrhosis by assaying the differential expression of proteins encoded by SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof.

Abstract: A pharmaceutical preparation containing polymeric compounds as shown in the specification. This preparation can be used to improve liver function and treat liver disease, and promoting liver tissue regeneration.

Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.

Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.

Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.

Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.

Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.

Abstract: Method for producing itaconic acid in yeast cells using glycerol as the substrate. The yeast cells express cis-aconitic acid decarboxylase and optionally, citrate synthase and/or aconitase at high levels.

Abstract: An apparatus for anulus fibrosus repair includes a shaft, a pair of curved suturing needles mounted in parallel on the shaft, and a rotational driving mechanism connected to the shaft, which is configured to rotate the shaft and the pair of needles about a rotation axis of the shaft. Each needle includes a substantially semi-annular body having a proximal end, a distal end, an inner periphery, and an outer periphery, and an arm extending radially inward from the proximal end, in which a concavity is formed in the body proximate to the distal end extending in a direction away from it. Also disclosed is a suturing technique associated with use of the repair apparatus.

Abstract: The present invention relates to methods of diagnosing myasthenia gravis in a subject, by determining an amount of at least one autoantibody that specifically binds one or more autoantigens selected from heat-shock protein 60 (hsp60), heat-shock protein 90, alpha isoform (hsp90?), and heat-shock protein 90, beta isoform (hsp90?). The invention also provides diagnostic kits for identifying a subject having myasthenia gravis.

Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.